Mineralys Therapeutics
MLYS
MLYS
108 hedge funds and large institutions have $572M invested in Mineralys Therapeutics in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 44 increasing their positions, 17 reducing their positions, and 14 closing their positions.
Holders
108
Holders Change
+2
Holders Change %
+1.89%
% of All Funds
1.44%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
16
Increased
44
Reduced
17
Closed
14
Calls
$1K
Puts
$8K
Net Calls
-$7K
Net Calls Change
-$50K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$13.6M |
| 2 |
IHAM
2
Integral Health Asset Management
New York
|
$10.8M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$6.2M |
| 4 |
SC
4
Stempoint Capital
New York
|
$4.93M |
| 5 |
5
Jennison Associates
New York
|
$13.3M |
